Breaking News
Sort by:
Date
Top Post
FDA Accepts Eisai's Filing of a Supplemental Biologics License Application and Grants Priority Review for Traditional Approval of LEQEMBITM (lecanemab-irmb) for the Treatment of Alzheimer's Disease
Eisai and Biogen announced today that the US Food and Drug Administration (FDA) has accepted […]
New UK-wide Ambitions to Accelerate Genomic Research and Drive Innovation in Healthcare
Patients across the UK are set to benefit from faster cancer diagnosis and innovative new […]
£64 Million Funding to Back UK-wide Plan to Strengthen Clinical Research Delivery
Better health outcomes through more effective and efficient research as seen throughout the pandemic Promoting […]
New UK Strategy Sets out Ambition to Be World Leaders in Organ Donation and Transplantation
Increasing consent rates for organ donation and making the most of donated organs for transplant […]
- Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa Read more
- Celyad Oncology Appoints Georges Rawadi as Its New CEO Read more
- Companion Spine Closes $60.1 Million Series A Funding Round Read more
- EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis Read more
- Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer Read more